Dual Antiplatelet Therapy or Dual Pathway Inhibition
Thrombosis and Haemostasis · 01.03.2024 · 124 (03) · 274-276
DOI: 10.1055/a-2191-7627 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.03.2024. Verfasst von Shinya Goto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Cardiology), Department of General Medicine, Tokai University School of Medicine, Isehara, Japan. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Aspirin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Cardiology), Department of General Medicine, Tokai University School of Medicine, Isehara, Japan.
ORCID-Profile: Shinya Goto, Shinichi Goto
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Agency for Medical Research and Development
Zitieren
APA
Goto, S., & Goto, S. (2024). Dual Antiplatelet Therapy or Dual Pathway Inhibition. Thrombosis and Haemostasis, 124(03), 274-276. https://doi.org/10.1055/a-2191-7627
Vancouver
Goto S, Goto S. Dual Antiplatelet Therapy or Dual Pathway Inhibition. Thrombosis and Haemostasis. 2024;124(03):274-276. doi:10.1055/a-2191-7627
BibTeX
@article{Goto2024,
author = {Goto, Shinya and Goto, Shinichi},
title = {Dual Antiplatelet Therapy or Dual Pathway Inhibition},
journal = {Thrombosis and Haemostasis},
year = {2024},
volume = {124},
number = {03},
pages = {274--276},
doi = {10.1055/a-2191-7627}
}
EUVIMED